[1-[4-[7-(2-azaniumyl-3-phenylpropanoyl)oxy-5-hydroxy-4-oxochromen-3-yl]phenoxy]-1-oxo-3-phenylpropan-2-yl]azanium
Formula:C33H30N2O7
Mutagenic:high
Tumorigenic:none
Reproductive Effective:high
[1-[4-[7-(2-azaniumyl-3-phenylpropanoyl)oxy-5-hydroxy-4-oxochromen-3-yl]phenoxy]-1-oxo-3-phenylpropan-2-yl]azanium is not a drug-like molecule.
| MolName | [1-[4-[7-(2-azaniumyl-3-phenylpropanoyl)oxy-5-hydroxy-4-oxochromen-3-yl]phenoxy]-1-oxo-3-phenylpropan-2-yl]azanium |
| MolecularFormula | C33H30N2O7 |
| Smiles | [NH3+]C(Cc1ccccc1)C(Oc(cc1)ccc1C1=COc(cc(cc2O)OC(C(Cc3ccccc3)[NH3+])=O)c2C1=O)=O |
| InChI | InChI=1S/C33H28N2O7/c34-26(15-20-7-3-1-4-8-20)32(38)41-23-13-11-22(12-14-23)25-19-40-29-18-24(17-28(36)30(29)31(25)37)42-33(39)27(35)16-21-9-5-2-6-10-21/h1-14,17-19,26-27,36H,15-16,34-35H2/p+2 |
| InChIK | RXLFEWISUXVFFT-UHFFFAOYSA-P |
| TotalMolweight | 566.608 |
| Molweight | 566.608 |
| MonoisotopicMass | 566.205303 |
| CLogP | -3.0962 |
| CLogS | -6.083 |
| H Acceptors | 9 |
| H Donors | 3 |
| TotalSurfaceArea | 421.33 |
| Relative PSA | 0.26388 |
| PolarSurfaceArea | 154.41 |
| Druglikeness | -0.8991 |
| Mutagenic | high |
| Tumorigenic | none |
| Reproductive Effective | high |
| Irritant | none |
| Nasty Functions | |
| Shape Index | 0.61905 |
| Fragments | 1 |
| Non HAtoms | 42 |
| NonCHAtoms | 9 |
| Electronegative Atoms | 9 |
| StereoCenters | 2 |
| Rotatable Bond | 11 |
| Rings Closures | 5 |
| Small Rings | 5 |
| Aromatic Rings | 4 |
| Aromatic Atoms | 24 |
| Sp3Atoms | 10 |
| Symmetricatoms | 6 |
| Amines | 2 |
| AlkylAmines | 2 |
| BasicNitrogens | 2 |
| StereoCon | unknown chirality |
Click to Load Molecule:
1 - [1-[4-[7-(2-azaniumyl-3-phenylpropanoyl)oxy-5-hydroxy-4-oxochromen-3-yl]phenoxy]-1-oxo-3-phenylpropan-2-yl]azanium | 2 - [1-[4-[7-(2-azaniumyl-3-phenylpropanoyl)oxy-5-hydroxy-4-oxochromen-3-yl]phenoxy]-1-oxo-3-phenylpropan-2-yl]azanium
Spacefill |
Wire |
Ball & Stick |
Iso-vdw |
Opaque |
Dot Surface |
Mep |
Translucent |
Spin |
Label On |
Off